Yi Zhu

4.6k citations
144 papers · 3.6k indexed · h-index 38
Topics
Cancer-related molecular mechanisms research (19 papers)Pancreatic and Hepatic Oncology Research (18 papers)MicroRNA in disease regulation (18 papers)
Journals
Nucleic Acids ResearchSHILAP Revista de lepidopterologíaAnalytical Chemistry

In The Last Decade

Yi Zhu

138 papers receiving 3.5k citations

Peers

Yi Zhu
Comparison fields: 5 of 127
  • Molecular Biology 1.9k
  • Cancer Research 1.0k
  • Oncology 778
  • Immunology 468
  • Surgery 423
Replace Guoxiong Xu with:
Guoxiong Xu China
Jie Ding China
Lin Zhao China
Shengtao Zhou China
Lu Sun China
Jichun Zhou China
Bing Xu China
Paola Lanuti Italy
Lin Zhang China
Hiroshi Yagi Japan
Yi Zhu relative to Guoxiong Xu China Guoxiong Xu's profile →
Citations per field
00.5×11×
Guoxiong Xu · 1×
Citations per year

Countries citing papers authored by Yi Zhu

Since Specialization
Citations

This map shows the geographic impact of Yi Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Zhu more than expected).

Fields of papers citing papers by Yi Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Zhu. The network helps show where Yi Zhu may publish in the future.

Co-authorship network of co-authors of Yi Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Zhu. A scholar is included among the top collaborators of Yi Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Zhu. Yi Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 10
3 0
4 3
5 2
6 1
7 1
8 7
9 12
10 3
11 1
12 22
13 2
14 41
15
Knockdown of a HIF-2α promoter upstream long noncoding RNA impairs colorectal cancer stem cell properties in vitro through HIF-2α downregulation
1
16 55
17 47
18 8
19 2
20 5

About Yi Zhu

Yi Zhu is a scholar working on Cancer Research, Obstetrics and Gynecology and Reproductive Medicine, having authored 144 papers that have together received 3.6k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (19 papers), Pancreatic and Hepatic Oncology Research (18 papers) and MicroRNA in disease regulation (18 papers). The work is most often cited by research in Cancer Research (1.0k citations), Oncology (778 citations) and Molecular Biology (1.9k citations). Yi Zhu has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Yi Miao, Xiangyi Zheng, Xin Xu, Liping Xie, Shenyin Zhu, Jiangchuan Sun, Zhigang Wang, Jian Wu, Shiqi Li and Guonan Zhang. Their work appears in journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Analytical Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026